Description
Seeking people aged 12 and older who have had either active or stable non-segmental vitiligo for at least three months for a study of an investigational drug.
Overview
Participants will either get the investigational drug or a placebo (looks like the drug but contains no medicine). There are at least 10 study visits over 60 weeks.
What we're hoping for
We are studying whether an investigational drug is safe and effective in preventing loss of skin pigmentation in people aged 12 and older with non-segmental vitiligo.
Additional Information
ClinicalTrials.gov Identifier: NCT05583526